Articles published by Ambrx
Ambrx Announces NovoCodex’s Dosing of First Patient with ARX305, Ambrx’s Investigational Antibody Drug Conjugate Targeting CD70
November 09, 2022
From Ambrx
Via Business Wire
Tickers
AMAM
Ambrx Biopharma Inc. Appoints Daniel O’Connor as Chief Executive Officer
November 01, 2022
From Ambrx
Via Business Wire
Tickers
AMAM
Ambrx Announces First Patient Dosed in a Phase 1 Trial for ARX517, an ADC in Development to Treat PSMA Expressing Tumors
August 03, 2021
From Ambrx
Via Business Wire
Tickers
AMAM
Ambrx Appoints Sonja Nelson as Chief Financial Officer
June 30, 2021
From Ambrx
Via Business Wire
Tickers
AMAM
Ambrx Announces Pricing of Initial Public Offering
June 17, 2021
From Ambrx
Via Business Wire
Tickers
AMAM
From Ambrx
Via Business Wire
From Ambrx
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>